Jiangxi Porton Pharmaceutical Co., Ltd. announced that it will receive CNY 334,802,800 in an equity round of funding from returning investor Porton Pharma Solutions Ltd. on February 28, 2022. The entire gross proceeds will be included in the company's capital reserve. Post closing, the registered capital of the company will remain CNY 100,000,000, and the investor will continue to hold 100% stake in the company.

The transaction has been approved in the resolution of the 40th interim meeting of the fourth board of directors, and 29th interim meeting of the fourth board of supervisors of the investor, and is subject to approval in investor' general meeting of shareholders.